SEPTInvestingStart Free

AMRX SCHEDULE 13D/A: SEC filing

An amendment to a Schedule 13D was

Filed with the SEC on · accession 0000898432-26-000652

AMRX filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Aug 12, 2026. An amendment to a Schedule 13D was filed for Amneal Pharmaceuticals, Inc. (AMRX), indicating a change in a previously reported beneficial ownership position by a major shareholder. The stock moved +3.3% by the first close after the filing.

Summary of the filing

An amendment to a Schedule 13D was filed for Amneal Pharmaceuticals, Inc. (AMRX), indicating a change in a previously reported beneficial ownership position by a major shareholder. The filing text provided does not disclose the specific details of the amendment.

For details, click here →

Key details

Subject companyAmneal Pharmaceuticals, Inc.

How AMRX stock reacted

Close before

$17.10

Aug 11, 2026

First close after

+3.27%

$17.66

5 trading days

+6.37%

$18.19

Since filing

+18.19%

$20.21

✦ Ask GOAX AI about this filing — what it means for AMRX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for AMRX?

Click here

Frequently asked questions

What did AMRX file with the SEC on Aug 12, 2026?

AMRX filed a SCHEDULE 13D/A (SEC filing). An amendment to a Schedule 13D was filed for Amneal Pharmaceuticals, Inc. (AMRX), indicating a change in a previously reported beneficial ownership position by a major shareholder. The filing text provided does not disclose the specific details of the amendment.

How do I read a SCHEDULE 13D/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).

How did AMRX stock react to this filing?

AMRX closed at $17.10 before the filing and $17.66 on Aug 12, 2026 (+3.27%). Five trading days later: $18.19 (+6.37%).

Other AMRX SEC filings

Get alerts when AMRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
AMRX overviewAMRX analysisAMRX newsLatest SEC filings